Evaluation of PCR-Reverse Dot Blot Human Papillomavirus Genotyping Test in Predicting Residual/Recurrent CIN 2+ in Posttreatment Patients in China

OBJECTIVE: To assess the clinical value of the PCR-reverse dot blot human papillomavirus genotyping test during follow-up of patients with CIN grade 2 or worse (CIN 2+). METHODS: Four hundred patients with CIN 2+ receiving treatment from January 2008 to January 2017 were included in our study. Posto...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Manag Res
Autores principales: Zhang, Qiaoyu, Dong, Binhua, Chen, Lihua, Lin, Tingting, Tong, Yao, Lin, Wenyu, Lin, Haifeng, Gao, Yuqin, Lin, Fen, Sun, Pengming
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7132552/
https://ncbi.nlm.nih.gov/pubmed/32308477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S237490
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares